NIAID CLINICAL DATA AND SAFETY MANAGEMENT CENTER (CDSMC)
NIAID CLINICAL DATA AND SAFETY MANAGEMENT CENTER (CDSMC)
批准号:
10493771
负责人:
DANIEL MOLINA
金额:
$781.9万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-15 至 2022-09-14
关键词:
Allergic DiseaseAreaAutoimmune DiseasesAwardCell TransplantationClinicalClinical DataClinical ResearchClinical TrialsContractorContractsData ReportingDiseaseExtrinsic asthmaFundingHypersensitivityImmuneImmune System DiseasesImmunologic Deficiency SyndromesImmunologyInternationalMediatingMissionNational Institute of Allergy and Infectious DiseaseOrgan TransplantationProcessResearchSafetySafety ManagementSolidSpecimenTissue TransplantationTransplantationWorkdata managementimmune functionpharmacovigilance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Through the contract award, the Division of Allergy, Immunology, and Transplantation intends to provide a Clinical Data and Safety Management Center (CDSMC) to support a wide range of clinical research data management, safety and pharmacovigilance management for NIAID-funded clinical trials and clinical studies of immune-mediated diseases. The Contractor will establish a CDSMC that will provide Data Management and Reporting, Clinical Safety and Pharmacovigilance, and a Specimen Tracking processes for NIAID supported clinical trials and studies (including mechanistic) for both domestic and/or international research. Primary scientific areas of support include allergic diseases and asthma; autoimmune disorders; immune-mediated rejection in solid organ, tissue and cell transplantation; primary immune deficiency disorders; and other immune system disorders and treatments to enhance immune functions but may expand to other NIAID sponsored areas
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE I COCAINE DRUG INTERACTION STUDY. TO6. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 08/10/2023 - 02/09/2025. NIDA REF. NO. N01DA-19-8947.
-
批准号:10937276
-
项目类别:
-
资助金额:$20.23万
-
财政年份:2023
-
负责人:DANIEL MOLINA
-
依托单位:
FY23. TO5. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 01/18/2022 - 04/16/2024. NIDA REF. NO. N01DA-19-8947.
-
批准号:10948307
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2022
-
负责人:DANIEL MOLINA
-
依托单位:
DATA COORDINATING CENTER FOR SPROUTS AGES 6- AND 7- YEARS ASSESSMENTS AND STUDY CLOSEOUT
-
批准号:10271537
-
项目类别:
-
资助金额:$75.52万
-
财政年份:2020
-
负责人:DANIEL MOLINA
-
依托单位:
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE OTHER SUPPORT SERVICES TO NIDA AS PART OF CONTRACT PERFORMANCE. SPECIFICALLY, THIS TO INVOLVES WORK DESCRIBED IN TASK G. THE SCOPE OF THIS TASK IS FOR SEV
-
批准号:10044188
-
项目类别:
-
资助金额:$2.44万
-
财政年份:2019
-
负责人:DANIEL MOLINA
-
依托单位:
DATA COORDINATING CENTER FOR THE STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN)
-
批准号:10021081
-
项目类别:
-
资助金额:$143.85万
-
财政年份:2019
-
负责人:DANIEL MOLINA
-
依托单位:
DATA COORDINATING CENTER FOR THE STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN)
-
批准号:10271386
-
项目类别:
-
资助金额:$25.58万
-
财政年份:2019
-
负责人:DANIEL MOLINA
-
依托单位:
THE PURPOSE OF THE TO REQUIREMENT IS TO CONDUCT A PHASE I STUDY OF CBD-MORPHINE DRUG-DRUG INTERACTION. TRI HAS CLEARLY DEFINED THE OBJECTIVES OF THE TO IN THEIR PROPOSAL SUBMISSION.
-
批准号:10044332
-
项目类别:
-
资助金额:$17.99万
-
财政年份:2019
-
负责人:DANIEL MOLINA
-
依托单位:
DATA COORDINATING CENTER FOR SPROUTS AGE 4 ASSESSMENTS
-
批准号:10025879
-
项目类别:
-
资助金额:$33.51万
-
财政年份:2019
-
负责人:DANIEL MOLINA
-
依托单位:
IGF::OT::IGF Task Order 4 for Clinical Support for a phase 1 clinical interaction study between lorcaserin and cocaine POP: 08/18/2014 -08/17/2015.
-
批准号:8951967
-
项目类别:
-
资助金额:$55.49万
-
财政年份:2014
-
负责人:DANIEL MOLINA
-
依托单位:
CANCER PREVENTION CLINICAL TRIALS AUDITING & INFORMATICS SUPPORT
-
批准号:9915793
-
项目类别:
-
资助金额:$47.93万
-
财政年份:2014
-
负责人:DANIEL MOLINA
-
依托单位:
CANCER PREVENTION CLINICAL TRIALS AUDITING & INFORMATICS SUPPORT
-
批准号:9262815
-
项目类别:
-
资助金额:$185.0万
-
财政年份:2014
-
负责人:DANIEL MOLINA
-
依托单位:
Cancer Prevention Clinical Trials Auditing & Informatics Support.
-
批准号:8949018
-
项目类别:
-
资助金额:$205.82万
-
财政年份:2014
-
负责人:DANIEL MOLINA
-
依托单位:
IGF::OT::IGF Task Order 4 for Clinical Support for a phase 1 clinical interaction study between lorcaserin and cocaine POP: 08/18/2014 -08/17/2015.
-
批准号:9430254
-
项目类别:
-
资助金额:$33.16万
-
财政年份:2014
-
负责人:DANIEL MOLINA
-
依托单位:
IGF::OT::IGF Task Order 4 for Clinical Support for a phase 1 clinical interaction study between lorcaserin and cocaine POP: 08/18/2014 -08/17/2015.
-
批准号:9038824
-
项目类别:
-
资助金额:$17.76万
-
财政年份:2014
-
负责人:DANIEL MOLINA
-
依托单位:
MEDICAL WRITING, REPORT PREPARATION AND PROJECT MANAGEMENT
-
批准号:7962707
-
项目类别:
-
资助金额:$6.76万
-
财政年份:2005
-
负责人:DANIEL MOLINA
-
依托单位:
CLINICAL AND DATA MANGEMENT SERVICES
-
批准号:8014339
-
项目类别:
-
资助金额:$41.47万
-
财政年份:2005
-
负责人:DANIEL MOLINA
-
依托单位:
CLINICAL AND DATA MANGEMENT SERVICES
-
批准号:7963309
-
项目类别:
-
资助金额:$88.45万
-
财政年份:2005
-
负责人:DANIEL MOLINA
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: